CANADA LIFE ASSURANCE Co - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$9,522,000
+82.2%
409,702
+24.9%
0.02%
+69.2%
Q1 2018$5,225,000
-18.4%
328,154
+6.5%
0.01%
-13.3%
Q4 2017$6,407,000
+30.5%
308,027
-12.5%
0.02%
+25.0%
Q3 2017$4,908,000
+12.0%
352,056
+38.7%
0.01%0.0%
Q2 2017$4,383,000
+60.2%
253,889
+2.0%
0.01%
+71.4%
Q1 2017$2,736,000
-22.1%
248,876
+3.1%
0.01%
-30.0%
Q4 2016$3,514,000
-86.9%
241,365
-77.9%
0.01%
-74.4%
Q3 2016$26,754,000
+138.7%
1,090,580
+94.4%
0.04%
+14.7%
Q2 2016$11,210,000
+3.6%
560,890
+36.0%
0.03%
-12.8%
Q1 2016$10,819,000
-84.0%
412,462
-38.0%
0.04%
-85.0%
Q4 2015$67,656,000
-69.2%
665,605
-46.1%
0.26%
-69.8%
Q3 2015$219,390,000
-41.5%
1,234,037
-27.0%
0.86%
-33.6%
Q2 2015$374,903,000
+12.2%
1,691,478
-0.3%
1.30%
+13.5%
Q1 2015$334,209,000
+31.5%
1,696,256
-4.4%
1.14%
+36.2%
Q4 2014$254,158,000
+6.6%
1,773,732
-2.5%
0.84%
+4.9%
Q3 2014$238,466,000
+4.7%
1,819,732
+0.6%
0.80%
+7.1%
Q2 2014$227,817,000
-3.3%
1,808,623
+0.6%
0.75%
-9.9%
Q1 2014$235,529,000
-9.2%
1,797,922
-18.5%
0.83%
-10.1%
Q4 2013$259,369,000
+18.0%
2,205,752
+4.6%
0.92%
+6.1%
Q3 2013$219,896,000
+13.3%
2,109,625
-6.3%
0.87%
-32.0%
Q2 2013$194,133,0002,250,3301.28%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2018
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders